3SBio Inc. | Mutual Funds
Mutual Funds that own 3SBio Inc.
Oppenheimer Developing Markets Fund
39,915,500
1.57%
-28,884,000
0.21%
02/28/2018
Harvest Overseas Chinese Equity Fund
21,702,000
0.85%
12,646,000
4.55%
12/31/2017
Government Pension Fund - Global (The)
17,910,539
0.7%
11,831,053
0%
12/31/2017
Dynamic Power Global Growth Class
17,365,441
0.68%
17,365,441
2.85%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
15,359,500
0.6%
-140,000
0.04%
07/31/2018
T Rowe Price International Discovery Fund
14,381,500
0.56%
0
0.31%
06/30/2018
Vanguard Total International Stock Index Fund
13,633,425
0.54%
0
0.01%
07/31/2018
Baring International Umbrella Fund - Hong Kong China Fund
13,029,500
0.51%
0
1.32%
10/31/2017
iShares Core MSCI Emerging Markets ETF
10,910,500
0.43%
0
0.04%
09/05/2018
T Rowe Price New Asia Fund
9,679,000
0.38%
1,980,500
0.64%
06/30/2018
| Address |
Shenyang Economy & Tech Development
Shenyang Liaoning 110027
China
|
|
Employees
|
- |
| Website |
http://www.3sbio.com |
| Updated |
07/08/2019 |
| 3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products. It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China. |
